BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$414M |
| 2 |
State Street Industrial Select Sector SPDR ETF
XLI
|
+$371M |
| 3 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$342M |
| 4 |
Microsoft
MSFT
|
+$339M |
| 5 |
iShares MSCI ACWI ETF
ACWI
|
+$296M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.2B |
| 2 |
Salesforce
CRM
|
+$688M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$338M |
| 4 |
Eli Lilly
LLY
|
+$239M |
| 5 |
AGN
Allergan plc
AGN
|
+$225M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.86% |
| 2 | Consumer Discretionary | 6.16% |
| 3 | Healthcare | 5.91% |
| 4 | Communication Services | 5.19% |
| 5 | Financials | 5.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
GOOD
3126
Gladstone Commercial Corp
GOOD
$628M
| $26.6K | ﹤0.01% |
1,420
-8,297
| -85% | -$136K |
|
3127
Crinetics Pharmaceuticals
CRNX
$8.98B
| $26.6K | ﹤0.01% |
1,516
-1,931
| -56% | -$32.9K |
|
3128
Cass Information Systems
CASS
$746M
| $26.5K | ﹤0.01% |
678
-3,679
| -84% | -$138K |
|
|
CBAY
3129
DELISTED
Cymabay Therapeutics
CBAY
| $26.3K | ﹤0.01% |
7,526
-17,486
| -70% | -$50.5K |
|
3130
Tenaris
TS
$27B
| $26.2K | ﹤0.01% |
2,029
+1,000
| +97% | +$13.2K |
|
|
RLH
3131
DELISTED
Red Lions Hotel Corporation
RLH
| $26.1K | ﹤0.01% |
11,205
+3,782
| +51% | +$6.76K |
|
3132
LeMaitre Vascular
LMAT
$1.86B
| $26K | ﹤0.01% |
986
-5,552
| -85% | -$145K |
|
|
GEN
3133
DELISTED
Genesis Healthcare, Inc.
GEN
| $26K | ﹤0.01% |
37,678
+11,723
| +45% | +$9.43K |
|
|
PETQ
3134
DELISTED
PetIQ, Inc. Class A Common Stock
PETQ
| $26K | ﹤0.01% |
746
-5,403
| -88% | -$152K |
|
|
LEAF
3135
DELISTED
Leaf Group Ltd.
LEAF
| $25.9K | ﹤0.01% |
7,070
+1,594
| +29% | +$3.31K |
|
3136
Medallion Financial
MFIN
$263M
| $25.9K | ﹤0.01% |
9,780
+3,429
| +54% | +$8.23K |
|
3137
LiveOne
LVO
$57.5M
| $25.9K | ﹤0.01% |
716
-400
| -36% | -$11.2K |
|
3138
Team
TISI
$101M
| $25.8K | ﹤0.01% |
463
-794
| -63% | -$43.9K |
|
3139
Flotek Industries
FTK
$1.29B
| $25.8K | ﹤0.01% |
3,583
+819
| +30% | +$4.69K |
|
|
SBOW
3140
DELISTED
SilverBow Resources, Inc.
SBOW
| $25.7K | ﹤0.01% |
8,010
+5,804
| +263% | +$23.4K |
|
3141
Sportsman's Warehouse
SPWH
$46.8M
| $25.6K | ﹤0.01% |
1,796
-11,357
| -86% | -$107K |
|
|
ELVT
3142
DELISTED
Elevate Credit, Inc.
ELVT
| $25.5K | ﹤0.01% |
17,263
+10,329
| +149% | +$18.1K |
|
|
PRGX
3143
DELISTED
PRGX Global, Inc.
PRGX
| $25.5K | ﹤0.01% |
5,419
-962
| -15% | -$3.45K |
|
|
MLVF
3144
DELISTED
Malvern Bancorp, Inc.
MLVF
| $25.4K | ﹤0.01% |
1,998
-350
| -15% | -$4.13K |
|
3145
Monarch Casino & Resort
MCRI
$2.23B
| $25.3K | ﹤0.01% |
741
-3,829
| -84% | -$127K |
|
|
HT
3146
DELISTED
Hersha Hospitality Trust Priority Class A Common Shares of Beneficial Interest
HT
| $25.2K | ﹤0.01% |
4,383
-10,308
| -70% | -$55K |
|
|
TVRD
3147
Tvardi Therapeutics
TVRD
$23.9M
| $25.2K | ﹤0.01% |
41
-303
| -88% | -$167K |
|
3148
Inseego
INSG
$78.8M
| $25.1K | ﹤0.01% |
216
-1,442
| -87% | -$152K |
|
|
RC
3149
Ready Capital
RC
$302M
| $25K | ﹤0.01% |
2,878
-11,296
| -80% | -$76.8K |
|
|
USCR
3150
DELISTED
U S Concrete, Inc.
USCR
| $24.9K | ﹤0.01% |
1,005
-5,356
| -84% | -$107K |
|
Similar funds
BNP Paribas Financial Markets's Q2 2020 Portfolio in Review
As of Q2 2020, BNP Paribas Financial Markets held 4,480 positions worth $56.7B, up 16% from $48.8B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
BNP Paribas Financial Markets withdrew a net $2.34B in Q2 2020, closing 174 positions and reducing 2,678 holdings. Its most notable exit was Allergan plc, an estimated $225M position sold in full.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 11% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, BNP Paribas Financial Markets opened a new position in State Street SPDR Portfolio Intermediate Term Corporate Bond ETF worth $35.2M.
- BNP Paribas Financial Markets's largest Q2 2020 buy was State Street SPDR Portfolio Intermediate Term Corporate Bond ETF: 962,483 shares worth $35.2M.
- BNP Paribas Financial Markets added most to Apple in Q2 2020, an estimated $414M increase.
- BNP Paribas Financial Markets's biggest Q2 2020 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.2B.
- BNP Paribas Financial Markets fully exited Allergan plc in Q2 2020, selling an estimated $225M.
- BNP Paribas Financial Markets's ten largest holdings make up 20% of its $56.7B portfolio in Q2 2020.
- BNP Paribas Financial Markets opened 164 new positions and closed 174 in Q2 2020.
- BNP Paribas Financial Markets's portfolio value rose 16% quarter-over-quarter to $56.7B.
Based on BNP Paribas Financial Markets's 13F filing for Q2 2020, filed 6 Aug 2020.